Literature DB >> 19813133

Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors.

Stephanie A Reid-Arndt1, Albert Yee, Michael C Perry, Catherine Hsieh.   

Abstract

Breast cancer survivors experience cognitive difficulties following chemotherapy, yet the effects of these deficits on functional outcomes have not been systematically evaluated. This study assessed the relationships between postchemotherapy cognitive difficulties and functional outcomes. Forty-six women with breast cancer were seen at 1-month postchemotherapy; data were collected on cognitive functioning, psychological variables, and physical symptoms. Wilcoxon signed-rank analyses revealed cognitive deficits in executive functioning and verbal fluency. Subsequent regression analyses demonstrated that poorer executive functioning was associated with decreased productivity, community involvement, and social role functioning. Poorer quality of life was predicted by depression and reluctance to seek social support, but not cognitive functioning. These findings indicate that executive functioning deficits are associated with important functional outcomes among breast cancer survivors 1-month postchemotherapy. Thus, treatment efforts should focus on addressing cognitive, as well as psychological and physical, issues among cancer survivors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19813133      PMCID: PMC2760006          DOI: 10.1080/07347330903183117

Source DB:  PubMed          Journal:  J Psychosoc Oncol        ISSN: 0734-7332


  55 in total

1.  Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

Authors:  Tim A Ahles; Andrew J Saykin; Charlotte T Furstenberg; Bernard Cole; Leila A Mott; Karen Skalla; Marie B Whedon; Sarah Bivens; Tara Mitchell; E Robert Greenberg; Peter M Silberfarb
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

2.  Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population.

Authors:  Inger Schou; Øivind Ekeberg; Leif Sandvik; Marianne J Hjermstad; Cornelia M Ruland
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

3.  A qualitative study of work and work return in cancer survivors.

Authors:  Deborah S Main; Carolyn T Nowels; Tia A Cavender; Martine Etschmaier; John F Steiner
Journal:  Psychooncology       Date:  2005-11       Impact factor: 3.894

4.  A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer.

Authors:  Angela Stewart; Catherine Bielajew; Barbara Collins; Matthew Parkinson; Eva Tomiak
Journal:  Clin Neuropsychol       Date:  2006-02       Impact factor: 3.535

5.  The relationship of neuropsychological status and productive outcomes following traumatic brain injury.

Authors:  D Girard; J Brown; M Burnett-Stolnack; N Hashimoto; S Hier-Wellmer; O Z Perlman; C Seigerman
Journal:  Brain Inj       Date:  1996-09       Impact factor: 2.311

6.  Age-related differences in the quality of life of breast carcinoma patients after treatment.

Authors:  L B Wenzel; D L Fairclough; M J Brady; D Cella; K M Garrett; B C Kluhsman; L A Crane; A C Marcus
Journal:  Cancer       Date:  1999-11-01       Impact factor: 6.860

7.  Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

Authors:  M J Brady; D F Cella; F Mo; A E Bonomi; D S Tulsky; S R Lloyd; S Deasy; M Cobleigh; G Shiomoto
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

8.  The role of disclosure patterns and unsupportive social interactions in the well-being of breast cancer patients.

Authors:  Melissa I Figueiredo; Elizabeth Fries; Kathleen M Ingram
Journal:  Psychooncology       Date:  2004-02       Impact factor: 3.894

9.  Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.

Authors:  Nadine Tchen; Helen G Juffs; Fiona P Downie; Qi-Long Yi; Hanxian Hu; Irene Chemerynsky; Mark Clemons; Michael Crump; Paul E Goss; David Warr; Mary E Tweedale; Ian F Tannock
Journal:  J Clin Oncol       Date:  2003-11-15       Impact factor: 44.544

Review 10.  Cognitive impairment associated with chemotherapy for cancer: report of a workshop.

Authors:  Ian F Tannock; Tim A Ahles; Patricia A Ganz; Frits S Van Dam
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

View more
  47 in total

Review 1.  An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors.

Authors:  Yin Ting Cheung; Earl Hsien-Jie Tan; Alexandre Chan
Journal:  Support Care Cancer       Date:  2012-04-05       Impact factor: 3.603

Review 2.  Chemotherapy-related cognitive dysfunction.

Authors:  Jeffrey S Wefel; Sanne B Schagen
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

Review 3.  Embracing the complexity: Older adults with cancer-related cognitive decline-A Young International Society of Geriatric Oncology position paper.

Authors:  Mackenzi Pergolotti; Nicolò Matteo Luca Battisti; Lynne Padgett; Alix G Sleight; Maya Abdallah; Robin Newman; Kathleen Van Dyk; Kelley R Covington; Grant R Williams; Frederiek van den Bos; YaoYao Pollock; Elizabeth A Salerno; Allison Magnuson; Isabella F Gattás-Vernaglia; Tim A Ahles
Journal:  J Geriatr Oncol       Date:  2019-10-14       Impact factor: 3.599

Review 4.  An update on cancer- and chemotherapy-related cognitive dysfunction: current status.

Authors:  Michelle C Janelsins; Sadhna Kohli; Supriya G Mohile; Kenneth Usuki; Tim A Ahles; Gary R Morrow
Journal:  Semin Oncol       Date:  2011-06       Impact factor: 4.929

Review 5.  Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?

Authors:  Wilbert Zwart; Huub Terra; Sabine C Linn; Sanne B Schagen
Journal:  Nat Rev Clin Oncol       Date:  2015-07-21       Impact factor: 66.675

Review 6.  Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer Treatments.

Authors:  Karen M Mustian; Calvin L Cole; Po Ju Lin; Matt Asare; Chunkit Fung; Michelle C Janelsins; Charles S Kamen; Luke J Peppone; Allison Magnuson
Journal:  Semin Oncol Nurs       Date:  2016-10-21       Impact factor: 2.315

Review 7.  Clearing the air: a review of our current understanding of "chemo fog".

Authors:  Erin O'Farrell; Joyce MacKenzie; Barbara Collins
Journal:  Curr Oncol Rep       Date:  2013-06       Impact factor: 5.075

8.  The perceptions of Australian oncologists about cognitive changes in cancer survivors.

Authors:  Kate Smidt; Lynette Mackenzie; Haryana Dhillon; Janette Vardy; Joanne Lewis; Siew Yim Loh
Journal:  Support Care Cancer       Date:  2016-06-20       Impact factor: 3.603

Review 9.  Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.

Authors:  Jeffrey S Wefel; Shelli R Kesler; Kyle R Noll; Sanne B Schagen
Journal:  CA Cancer J Clin       Date:  2014-12-05       Impact factor: 508.702

10.  The Feasibility of Using Metacognitive Strategy Training to Improve Cognitive Performance and Neural Connectivity in Women with Chemotherapy-Induced Cognitive Impairment.

Authors:  Timothy J Wolf; Meghan Doherty; Dorina Kallogjeri; Rebecca S Coalson; Joyce Nicklaus; Cynthia X Ma; Bradley L Schlaggar; Jay Piccirillo
Journal:  Oncology       Date:  2016-07-23       Impact factor: 2.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.